Caliway Biopharmaceuticals Co Ltd

Caliway Biopharmaceuticals Co Ltd

TTWSE:6919
73.80
TWD
-2.20
(-2.89%)
-0.17EPS
155.33BMarket Cap
Nov 11Next Earn

Latest Stock Split

Jul 21, 2025

10:1

For every share held, investors received 10. The price per share adjusted from $1215.00 to $121.50.

The split itself did not change the total investment value.

Use this split data in your app

Build with our data

Stock Split History

  1. Jul 21, 2025
    Before$1215.00
    Split ratio10:1
    After$121.50
    Forward
  2. Mar 21, 2024
    Before—
    Split ratio2:1
    After—
    Forward

About Caliway Biopharmaceuticals Co Ltd stock splits

Caliway Biopharmaceuticals Co Ltd (TWSE:6919) operates in the Biotechnology industry.

Caliway Biopharmaceuticals Co Ltd company overview

When did Caliway Biopharmaceuticals Co Ltd stock split?

Caliway Biopharmaceuticals Co Ltd's most recent stock split was on July 21, 2025. It was a 10-for-1 forward split, so shareholders received 10 shares for every share they held.

What is Caliway Biopharmaceuticals Co Ltd's stock split history?

Caliway Biopharmaceuticals Co Ltd (TWSE:6919) has split its stock 2 times: a 2-for-1 split on March 21, 2024 and a 10-for-1 split on July 21, 2025.

How many times has Caliway Biopharmaceuticals Co Ltd stock split?

Caliway Biopharmaceuticals Co Ltd has split its stock 2 times. This history records 2 forward splits between March 21, 2024 and July 21, 2025.

What is a stock split?

A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Caliway Biopharmaceuticals Co Ltd's 10-for-1 split on July 21, 2025, every share became 10 shares.

Will Caliway Biopharmaceuticals Co Ltd split its stock again?

Caliway Biopharmaceuticals Co Ltd has not announced a new split in our records. Its most recent split was on July 21, 2025, 1 year ago. Companies announce splits in advance, and any new TWSE:6919 split will appear on this page.